Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 82804-144

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 82804-144). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Atorvastatinfigure1. (Atorvastatinfigure1)

Atorvastatinfigure1. (Atorvastatinfigure1)
Chemical structure illustration of atorvastatin calcium dihydrate showing its molecular configuration including calcium ions and water molecules.*
FDA Label Image

Atorvastatinfigure2. (Atorvastatinfigure2)

Atorvastatinfigure2. (Atorvastatinfigure2)
A line graph showing cumulative incidence percentages over time in years for two groups labeled as 'Atorvastatin' and 'Placebo.' The Atorvastatin group shows a consistently lower cumulative incidence compared to the Placebo group over approximately 3.5 years, with statistical data including a hazard ratio and a p-value noted on the graph.*
FDA Label Image

Atorvastatinfigure3. (Atorvastatinfigure3)

Atorvastatinfigure3. (Atorvastatinfigure3)
A line graph comparing cumulative hazard percentages over time between placebo and atorvastatin groups. The x-axis shows time to the first primary endpoint through four years of follow-up, and the y-axis displays cumulative hazard percentage. Two lines represent placebo (dashed) and atorvastatin (solid), with atorvastatin showing lower cumulative hazard. A hazard ratio (HR) of 0.63 with confidence interval (0.48-0.83) and p-value of 0.001 is noted.*
FDA Label Image

Atorvastatinfigure4. (Atorvastatinfigure4)

Atorvastatinfigure4. (Atorvastatinfigure4)
A Kaplan-Meier survival curve graph depicting time to first major cardiovascular endpoint over five years. It compares atorvastatin 10 mg and atorvastatin 80 mg doses, showing the proportion of subjects experiencing events on the vertical axis with a hazard ratio and p-value noted.*
FDA Label Image

82804-144-90 (Atorvastatinfigure5)

82804-144-90 (Atorvastatinfigure5)
Label for Atorvastatin Calcium 10 mg tablets by Proficient Rx LP, a prescription human drug. The label shows a quantity of 90 film-coated tablets. Each tablet is described as white to off-white, oval, and biconvex with debossed '10' and 'A 53' markings. Manufactured by Annora Pharma Pvt. Ltd. in Telangana, India. Storage recommended at 20°-25°C.*
FDA Label Image

Atorvastatinfigure9 (Atorvastatinfigure9)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.